Hwang, D. Y., Eom, J., Jang, J. E., Jeung, H., Chung, H., Kim, J. S., . . . Min, Y. H. (2020). ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. J Exp Clin Cancer Res.
Dyfyniad Arddull ChicagoHwang, Doh Yu, Ju-In Eom, Ji Eun Jang, Hoi-Kyung Jeung, Haerim Chung, Jin Seok Kim, June-Won Cheong, and Yoo Hong Min. "ULK1 Inhibition As a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia." J Exp Clin Cancer Res 2020.
Dyfyniad MLAHwang, Doh Yu, et al. "ULK1 Inhibition As a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia." J Exp Clin Cancer Res 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.